MICROPORT (00853.HK) shares surged 5.20% in the pre-market trading session on Thursday, following the announcement of a non-binding proposal for the strategic restructuring of its Cardiac Rhythm Management (CRM) business.

The company revealed plans to consolidate its CRM business with MicroPort CardioFlow Medtech Corporation, a move that investors seem to view positively. This restructuring initiative is seen as a strategic step to streamline operations and potentially enhance the company's market position in the cardiac medical devices sector.

While details of the proposal remain limited, the market's immediate reaction suggests optimism about the potential synergies and growth opportunities this consolidation might bring. Investors will likely be watching closely for further developments and the finalization of this non-binding proposal, as it could significantly impact MICROPORT's future business structure and performance in the competitive medical technology landscape.